1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Global Gastroesophageal Reflux Disease Therapeutics Market Product Overview
4. Global Gastroesophageal Reflux Disease Therapeutics Market: An Analysis
4.1 Market Size, By Value, Year 2016-2026
Table 1: Global Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 2: Projected global population (In Billions)
Table 3: Population ages 65 and above, By Select Region, 2016-2020 (% of total)
Table 4: Projected global population aged 60 years & above (In Billions)
Table 5: Prevalence of Gastroesophageal Reflux Disease , By Region, 2017 (In %)
Table 6: Prevalence of GERD and Estimated Population in United States and EU 5
4.2 COVID-19 Impact on Gastroesophageal Reflux Disease Therapeutics Market
5. Global Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type (By Value)
5.1 Competitive Scenario of Global Gastroesophageal Reflux Disease Therapeutics Market: By Drug Type
Table 7: Global Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type Market Share, 2020 & 2026
5.2 Antacids - Market Size and Forecast (2016-2026)
Table 8: Global Gastroesophageal Reflux Disease Therapeutics Market- By Antacids, By Value (USD Million), 2016-2026
5.3 H2 Receptor Blockers - Market Size and Forecast (2016-2026)
Table 9: Global Gastroesophageal Reflux Disease Therapeutics Market- By H2 Receptor Blockers, By Value (USD Million), 2016-2026
5.4 Proton Pump Inhibitors - Market Size and Forecast (2016-2026)
Table 10: Global Gastroesophageal Reflux Disease Therapeutics Market- By Proton Pump Inhibitors, By Value (USD Million), 2016-2026
6. Global Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Distribution Channel (By Value)
6.1 Competitive Scenario of Global Gastroesophageal Reflux Disease Therapeutics Market: By Distribution Channel
Table 11: Global Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel Market Share, 2020 & 2026
6.2 Hospital Pharmacies - Market Size and Forecast (2016-2026)
Table 12: Global Gastroesophageal Reflux Disease Therapeutics Market- By Hospital Pharmacies, By Value (USD Million), 2016-2026
6.3 Retail Pharmacies - Market Size and Forecast (2016-2026)
Table 13: Global Gastroesophageal Reflux Disease Therapeutics Market- By Retail Pharmacies, By Value (USD Million), 2016-2026
6.4 Online Pharmacies - Market Size and Forecast (2016-2026)
Table 14: Global Gastroesophageal Reflux Disease Therapeutics Market- By Online Pharmacies, By Value (USD Million), 2016-2026
7. Global Gastroesophageal Reflux Disease Therapeutics Market: Regional Analysis
7.1 Competitive Scenario of Global Gastroesophageal Reflux Disease Therapeutics Market: By Region
Table 15: Global Gastroesophageal Reflux Disease Therapeutics Market- By Region Market Share, 2020 & 2026
8. North America Gastroesophageal Reflux Disease Therapeutics Market: An Analysis (2016-2026)
8.1 North America Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 16: North America Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 17: North America Healthcare Cost Per Capita, 2018 (USD)
Table 18: North America Population above 65 year, 2015, 2030F, & 2050F (In Millions)
8.2 North America Gastroesophageal Reflux Disease Therapeutics Market - Prominent Companies
8.3 Market Segmentation By Drug Type (Antacids, H2 Receptor Blockers and Proton Pump Inhibitors)
Table 19: North America Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
8.4 Market Segmentation By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)
Table 20: North America Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
8.5 North America Gastroesophageal Reflux Disease Therapeutics Market: Country Analysis
8.6 Market Opportunity Chart of North America Gastroesophageal Reflux Disease Therapeutics Market - By Country, By Value (Year-2026)
Table 21: Market Opportunity Chart of North America Gastroesophageal Reflux Disease Therapeutics Market- By Country, By Value (Year-2026)
8.7 Competitive Scenario of North America- By Country
Table 22: North America Gastroesophageal Reflux Disease Therapeutics Market- By Country Market Share, 2020 & 2026
8.8 United States Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 23: United States Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 24: United States Per Capita Expenditure on Healthcare, 2012-2018 (In USD)
Table 25: United States healthcare expenditure as percentage of GDP
8.9 Prominent Companies in Gastroesophageal Reflux Disease Therapeutics Market
8.10 United States Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type and Distribution Channel.
Table 26: United States Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
Table 27: United States Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
8.11 Canada Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 28: Canada Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 29: Canada Gastroesophageal Reflux Disease Facts
8.12 Canada Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type and Distribution Channel.
Table 30: Canada Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
Table 31: Canada Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
9. Europe Gastroesophageal Reflux Disease Therapeutics Market: An Analysis (2016-2026)
9.1 Europe Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 32: Europe Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 33: Population ages 65 and above (% of total population) - European Union
Table 34: Gross domestic expenditure on R&D (GERD) as a % of GDP in selected European countries
Table 35: Per Capita Health Expenditure, By Select Country, 2018 (USD)
Table 36: Breakdown of Total Health Expenditure in Europe, 2018 (%)
9.2 Europe Gastroesophageal Reflux Disease Therapeutics Market - Prominent Companies
9.3 Market Segmentation By Drug Type (Antacids, H2 Receptor Blockers and Proton Pump Inhibitors)
Table 37: Europe Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
9.4 Market Segmentation By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)
Table 38: Europe Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
9.5 Europe Gastroesophageal Reflux Disease Therapeutics Market: Country Analysis
9.6 Market Opportunity Chart of Europe Gastroesophageal Reflux Disease Therapeutics Market - By Country, By Value (Year-2026)
Table 39: Market Opportunity Chart of Europe Gastroesophageal Reflux Disease Therapeutics Market- By Country, By Value (Year-2026)
9.7 Competitive Scenario of Europe- By Country
Table 40: Europe Gastroesophageal Reflux Disease Therapeutics Market, By Country, 2020, 2026
9.8 Germany Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 41: Germany Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table A: Health expenditures in Germany as share of GDP and in millions of Euro
9.9 Prominent Companies in Gastroesophageal Reflux Disease Therapeutics Market
9.10 Germany Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type and Distribution Channel.
Table 42: Germany Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
Table 43: Germany Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
9.11 France Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 44: France Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table B: % OF ADULT POPULATION WITH GASTROINTESTINAL CONDITIONS IN FRANCE
Table C: % OF ADULT POPULATION WITH MEDICATION USAGE FOR GASTROINTESTINAL CONDITIONS IN FRANCE
9.12 France Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type and Distribution Channel.
Table 45: France Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
Table 46: France Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
9.13 United Kingdom Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 47: United Kingdom Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table D: Factor for Gastrointestinal Conditions in United Kingdom based on the age group
9.14 Prominent Companies in Gastroesophageal Reflux Disease Therapeutics Market
9.15 United Kingdom Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type and Distribution Channel.
Table 48: United Kingdom Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
Table 49: United Kingdom Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
9.16 Italy Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 50: Italy Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 51: Share of individuals affected by gastroesophageal reflux disease in Italy in 2009 and 2018
Table 52: Share of individuals affected by gastroesophageal reflux disease in Italy as of 2018, by gender
9.17 Italy Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type and Distribution Channel.
Table 53: Italy Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
Table 54: Italy Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
9.18 Spain Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 55: Spain Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table E: % OF ADULT POPULATION WITH GASTROINTESTINAL CONDITIONS IN SPAIN
9.19 Spain Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type and Distribution Channel.
Table 56: Spain Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
Table 57: Spain Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
10. Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market: An Analysis (2016-2026)
10.1 Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 58: Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 59: Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total)
Table 60: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
Table F: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
10.2 Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market - Prominent Companies
10.3 Market Segmentation By Drug Type (Antacids, H2 Receptor Blockers and Proton Pump Inhibitors)
Table 61: Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
10.4 Market Segmentation By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)
Table 62: Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
10.5 Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market: Country Analysis
10.6 Market Opportunity Chart of Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market - By Country, By Value (Year-2026)
Table 63: Market Opportunity Chart of Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market- By Country, By Value (Year-2026)
10.7 Competitive Scenario of Asia Pacific- By Country
Table 64: Asia Pacific Gastroesophageal Reflux Disease Therapeutics Market, By Country, 2020, 2026
10.8 China Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 65: China Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 66: Share of overweight population in China as of 2019, by gender
Table 67: Share of adult population who smoke in China from 2014 to 2018, by gender
10.9 China Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type and Distribution Channel.
Table 68: China Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
Table 69: China Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
10.10 Japan Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 70: Japan Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 71: Vonoprazan Sales in Japan, in USD Million from 2015 - 2020
Table 72: Japan Healthcare Expenditure Outlook (%)
Table 73: Japan Median Age of population from 2010 to 2050 (in years)
Table 74: Top Pharma Companies In Japan, based on sales in 2019, USD Billions
Table 75: Domestic private health expenditure (% of current health expenditure) - Japan
10.11 Prominent Companies in Gastroesophageal Reflux Disease Therapeutics Market
10.12 Japan Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type and Distribution Channel.
Table 76: Japan Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
Table 77: Japan Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
10.13 India Gastroesophageal Reflux Disease Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 78: India Gastroesophageal Reflux Disease Therapeutics Market Size, By Value, 2016-2026 (USD Million)
10.14 India Gastroesophageal Reflux Disease Therapeutics Market Segmentation By Drug Type and Distribution Channel.
Table 79: India Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type, By Value (USD Million), 2016-2026
Table 80: India Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel, By Value (USD Million), 2016-2026
11. Global Gastroesophageal Reflux Disease Therapeutics Market Dynamics
11.1 Global Gastroesophageal Reflux Disease Therapeutics Market Drivers
11.2 Global Gastroesophageal Reflux Disease Therapeutics Market Restraints
11.3 Global Gastroesophageal Reflux Disease Therapeutics Market Trends
12. Market Attractiveness
12.1 Market Attractiveness Chart of Global Gastroesophageal Reflux Disease Therapeutics Market - By Drug Type, By Value (Year-2026)
Table 81: Market Attractiveness Chart of Global Gastroesophageal Reflux Disease Therapeutics Market- By Drug Type (Year-2026)
12.2 Market Attractiveness Chart of Global Gastroesophageal Reflux Disease Therapeutics Market - By Distribution Channel, By Value (Year-2026)
Table 82: Market Attractiveness Chart of Global Gastroesophageal Reflux Disease Therapeutics Market- By Distribution Channel (Year-2026)
12.3 Market Attractiveness Chart of Global Gastroesophageal Reflux Disease Therapeutics Market - By Region, By Value (Year-2026)
Table 83: Market Attractiveness Chart of Global Gastroesophageal Reflux Disease Therapeutics Market- By Region (Year-2026)
13. Competitive Landscape
13.1 Market Share Analysis
Table 84: Global Gastroesophageal Reflux Disease Therapeutics company market share (%), 2020
13.2 Gastroesophageal Reflux Disease Therapeutics Pipeline
14. Company Profiles (Business Description, Financial Analysis, Business Strategy)
14.1 Phathom Pharmaceuticals
Table G: Upcoming potential pipeline catalysts
14.2 Eisai
Table 85: Eisai Annual Sales Revenue (USD Million), 2016-2020
Table 86: Eisai Annual Net Income/Loss (USD Million), 2016-2020
Table 87: Eisai sales Revenues, By Business Segment (%), FY2020
Table 88: Eisai sales Revenue, By Geographical Segment (%), FY2020
14.3 Takeda Pharmaceutical Company
Table 89: Takeda Pharmaceutical Company Annual Sales Revenue (USD Million), 2016-2020
Table 90: Takeda Pharmaceutical Company Annual Net Income/Loss (USD Million), 2016-2020
Table 91: Takeda Pharmaceutical Company sales Revenues, By Business Segment (%), FY2020
Table 92: Takeda Pharmaceutical Company sales Revenue, By Geographical Segment (%), FY2020
Table H: Takecab (Takeda) the first-line therapy for GERD
14.4 Daewoong Pharmaceutical
Table 93: Daewoong Pharmaceutical Annual Sales Revenue (USD Million), 2016-2020
Table 94: Daewoong Pharmaceutical Annual Net Income/Loss (USD Million), 2016-2020
14.5 Ironwood Pharmaceuticals
Table 95: Ironwood Pharmaceuticals Annual Sales Revenue (USD Million), 2016-2020
Table 96: Ironwood Pharmaceuticals Annual Net Income/Loss (USD Million), 2016-2020
Table 97: Ironwood Pharmaceuticals sales Revenues, By Geography Segment (%), FY2019
Table 98: Ironwood Pharmaceuticals sales Revenue, By Geographical Segment (%), FY2020
14.6 Johnson & Johnson
Table 99: Johnson & Johnson Annual Sales Revenue (USD Million), 2016-2020
Table 100: Johnson & Johnson Annual Net Income/Loss (USD Million), 2016-2020
Table 101: Johnson & Johnson sales Revenues, By Business Segment (%), FY2020
Table 102: Johnson & Johnson sales Revenue, By Geographical Segment (%), FY2020
14.7 EndoGastric Solutions
14.8 CHEPLAPHARM Arzneimittel
14.9 Merck & Co.
Table 103: Merck & Co. Annual Sales Revenue (USD Million), 2016-2020
Table 104: Merck & Co. Annual Net Income/Loss (USD Million), 2016-2020
Table 105: Merck & Co. sales Revenues, By Business Segment (%), FY2020
Table 106: Merck & Co. sales Revenue, By Geographical Segment (%), FY2020
14.10 Olympus Corporation
Table 107: Olympus Corporation Annual Sales Revenue (USD Million), 2017-2020
Table 108: Olympus Corporation Annual Net Income/Loss (USD Million), 2017-2020